Some studies limited the age of participants to 30 [25] or 35 years old [26], and one study had an additional participant inclusion criteria: individuals who were BRCA1/2 carriers with a 1.66% risk of BC over the next 5 years [26]. Here, BRCA1 is linked to breast cancer.